Shona Lang

Shona has gained experience working across a range of therapeutic areas, including oncology, macular disease, multiple sclerosis, cardiovascular disease, genetic biomarkers, and rare diseases. Her expertise covers all areas of systematic review methodology, including diagnostic reviews, rapid review, critical appraisal, burden of illness, epidemiology, treatment patterns, statistical reviewing, meta-analysis, and network meta-analysis.

Shona spent several years working in an Evidence Review Group providing single technology appraisals and diagnostic assessment reports for National Institute for Health and Care Excellence (NICE).

She also spent 15 years researching cancer cell biology. During her time in the laboratory, she worked closely with NHS clinicians and pathologists. She brings her insight of preclinical models, genomics, stem cells, gene therapy, and genetic biomarkers to support in the market access of emerging technologies and precision medicine. She maintains a strong interest in the application of evidence-based decision-making to preclinical research and wider clinical research.

Shona has a PhD in Cancer Studies from the University of Edinburgh.